RU2002127274A - USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA - Google Patents

USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA Download PDF

Info

Publication number
RU2002127274A
RU2002127274A RU2002127274/15A RU2002127274A RU2002127274A RU 2002127274 A RU2002127274 A RU 2002127274A RU 2002127274/15 A RU2002127274/15 A RU 2002127274/15A RU 2002127274 A RU2002127274 A RU 2002127274A RU 2002127274 A RU2002127274 A RU 2002127274A
Authority
RU
Russia
Prior art keywords
brain
treatment
vetom
time
hydrocephalia
Prior art date
Application number
RU2002127274/15A
Other languages
Russian (ru)
Original Assignee
Яско Анатолий Константинович (RU)
Яско Анатолий Константинович
Яско Олес Анатольевна (RU)
Яско Олеся Анатольевна
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Яско Анатолий Константинович (RU), Яско Анатолий Константинович, Яско Олес Анатольевна (RU), Яско Олеся Анатольевна filed Critical Яско Анатолий Константинович (RU)
Priority to RU2002127274/15A priority Critical patent/RU2002127274A/en
Publication of RU2002127274A publication Critical patent/RU2002127274A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Применение препарата Ветом-7048 впервые в качестве лекарственного препарата при лечении атрофии мозга, восстанавливает нервные клетки головного мозга и в лечении больных с гидроцефалией мозга.The use of Vetom-7048 for the first time as a medicine in the treatment of brain atrophy, restores brain nerve cells and in the treatment of patients with brain hydrocephalus.
RU2002127274/15A 2002-10-11 2002-10-11 USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA RU2002127274A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002127274/15A RU2002127274A (en) 2002-10-11 2002-10-11 USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002127274/15A RU2002127274A (en) 2002-10-11 2002-10-11 USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA

Publications (1)

Publication Number Publication Date
RU2002127274A true RU2002127274A (en) 2004-12-27

Family

ID=35610776

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002127274/15A RU2002127274A (en) 2002-10-11 2002-10-11 USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA

Country Status (1)

Country Link
RU (1) RU2002127274A (en)

Similar Documents

Publication Publication Date Title
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
IL225192A (en) Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury
EP2497501A3 (en) Radionuclides for medical use
CA2436799A1 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
IL166571A0 (en) Medical treatment system by substituting native biological regulatory function: cardiac pacing system blood pressure regulating system and cardiac disease treatment system based on the medical system
HUP0102489A2 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
FI956014A (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
WO2006004449A3 (en) A combination composition
EP1658853A4 (en) Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient
CY1112184T1 (en) PYRIDOXAMINE FOR USE IN TREATMENT OF DIABETIC Nephropathy in Type II Diabetes
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
DE50010284D1 (en) MEDICAMENT FOR THE TREATMENT OF BLOOD HIGH PRESSURE
DE60015560D1 (en) USE OF AMINO ACID FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF INSULIN RESISTANCE
AU2003219462A1 (en) Defibrillator/monitor with patient specific treatment algorithms
EP1393738A4 (en) Drugs for diabetes
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
WO2005063757A3 (en) Novel crystalline forms of temozolomide
RU2002127274A (en) USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
PL1663101T3 (en) Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
AU2003217432A1 (en) Angiopoietin-1 in the treatment of disease
RU2002109173A (en) A method for the treatment of degenerative diseases of the retina

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20050118